GLTO vs RARE · $1.73B cap vs rev $350.0M
Galecto Inc (GLTO) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Galecto Inc (GLTO) is a biotechnology company listed on NASDAQ.
Ultragenyx (RARE) is a biotechnology company listed on US.
GLTO does not have a complete income-statement cache yet.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
GLTO currently screens at market cap $1.73B. RARE currently screens at market cap $2.79B.
Not investment advice. Open the GLTO and RARE stock pages for the full models.
Not investment advice.